- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Nebraska Considers Elected Cannabis Commission
Lawmakers debate making the state's Medical Cannabis Commission an elected position.
Published on Feb. 2, 2026
Got story updates? Submit your updates here. ›
The Nebraska Legislature is considering a bill that would make the state's Medical Cannabis Commission an elected position, rather than an appointed one. Testimony was heard on Monday regarding the proposed legislation.
Why it matters
The debate over the structure of the Medical Cannabis Commission is part of Nebraska's ongoing efforts to establish a regulatory framework for the state's medical marijuana program, which was legalized in 2022. Making the commission an elected body could impact how the program is overseen and implemented.
The details
The proposed bill would change the current structure of the Medical Cannabis Commission, which is currently made up of appointees. Supporters argue that an elected commission would make the body more accountable to voters, while opponents raise concerns about the potential for political influence over the medical program.
- The Nebraska Legislature heard testimony on the bill on Monday, February 2, 2026.
The players
Nebraska Medical Cannabis Commission
The state-level regulatory body responsible for overseeing Nebraska's medical marijuana program.
The takeaway
The debate over the structure of Nebraska's Medical Cannabis Commission highlights the ongoing challenges states face in establishing effective regulatory frameworks for medical marijuana programs. The outcome of this legislation could have significant implications for how the state's medical cannabis industry is overseen and managed.



